Health CarePharmaceuticals & Biotechnology
  • Price (GBX)1,722.00
  • Today's Change-18.00 / -1.03%
  • Shares traded1.29k
  • 1 Year change24.06%
  • Beta0.7573
Data delayed at least 20 minutes, as of Jan 19 2017 08:23 GMT.
More ▼

Key statistics

As of last trade Genus PLC (GNS:LSE) traded at 1,722.00, -18.50% below its 52-week high of 2,113.00, set on Oct 05, 2016.
52-week range
1,281.00Jan 20 20162,113.00Oct 05 2016
Markit short selling activity
Previous close1,740.00
Average volume107.47k
Shares outstanding61.13m
Free float60.69m
P/E (TTM)21.64
Market cap1.06bn GBP
EPS (TTM)0.804 GBP
Annual div (ADY)22.14 GBX
Annual div yield (ADY)1.27%
Div ex-dateNov 17 2016
Div pay-dateDec 02 2016
Data delayed at least 20 minutes, as of Jan 19 2017 08:23 GMT.
More ▼

Investors Chronicle View

The last IC recommendation on Genus PLC shares was Hold at 1,968.00 on 08 Sep 2016Read the full article

Board of Directors


Bob Lawson, Non-Executive Chairman


Karim Bitar, Chief Executive


Stephen Wilson, Group Finance Director


Nigel Turner, Senior Non-Executive Director


Mike Buzzacott, Non-Executive Director


Lysanne Gray, Non-Executive Director


Duncan Maskell, Non-Executive Director


Lykele van der Broek, Non-Executive Director


Dan Hartley, Group General Counsel and Company Secretary

© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.